ReviewCurrent cardiology reports2022

Effects of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, on Cardiovascular Disease, Chronic Kidney Disease, and Blood Pressure.

Jonathan D Ravid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.